CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- 4 Open-market sale Chief Scientific Officer sold 5,778 shares at an average $18.24 ($105,409)
- 4 Open-market sale Chief Scientific Officer sold 26,454 shares at an average $17.10 ($452,483)
- 4 Open-market sale Chief Scientific Officer sold 58,546 shares at an average $18.30 ($1,071,422)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
Page 19 of 22 · 423 filings